Lipocine Inc
NASDAQ:LPCN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Lipocine Inc
NASDAQ:LPCN
|
US |
|
A
|
Ambitions Enterprise Management Co LLC
NASDAQ:AHMA
|
AE |
|
R
|
Rostelekom PAO
MOEX:RTKM
|
RU |
|
AVITA Medical Inc
NASDAQ:RCEL
|
US |
Wall Street
Price Targets
LPCN Price Targets Summary
Lipocine Inc
According to Wall Street analysts, the average 1-year price target for
LPCN
is 13.26 USD
with a low forecast of 11.11 USD and a high forecast of 15.75 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is LPCN's stock price target?
Price Target
13.26
USD
According to Wall Street analysts, the average 1-year price target for
LPCN
is 13.26 USD
with a low forecast of 11.11 USD and a high forecast of 15.75 USD.
What is Lipocine Inc's Revenue forecast?
Projected CAGR
9%
The
compound annual growth rate
of
Lipocine Inc's revenue for the next 3 years is
9%.